Description

Simple

Clinical

Overview

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Maltotetraose
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(R)-warfarin
The risk or severity of bleeding can be increased when Maltotetraose is combined with (R)-warfarin.
(S)-Warfarin
The risk or severity of bleeding can be increased when Maltotetraose is combined with (S)-Warfarin.
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Maltotetraose is combined with 4-hydroxycoumarin.
Acenocoumarol
The risk or severity of bleeding can be increased when Maltotetraose is combined with Acenocoumarol.
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Maltotetraose.
Clorindione
The risk or severity of bleeding can be increased when Maltotetraose is combined with Clorindione.
Coumarin
The risk or severity of bleeding can be increased when Maltotetraose is combined with Coumarin.
Dicoumarol
The risk or severity of bleeding can be increased when Maltotetraose is combined with Dicoumarol.
Diphenadione
The risk or severity of bleeding can be increased when Maltotetraose is combined with Diphenadione.
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Maltotetraose is combined with Ethyl biscoumacetate.
Fluindione
The risk or severity of bleeding can be increased when Maltotetraose is combined with Fluindione.
Lactulose
The therapeutic efficacy of Lactulose can be decreased when used in combination with Maltotetraose.
Phenindione
The risk or severity of bleeding can be increased when Maltotetraose is combined with Phenindione.
Phenprocoumon
The risk or severity of bleeding can be increased when Maltotetraose is combined with Phenprocoumon.
Picosulfuric acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Maltotetraose.
Tioclomarol
The risk or severity of bleeding can be increased when Maltotetraose is combined with Tioclomarol.
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Maltotetraose.
Warfarin
The risk or severity of bleeding can be increased when Maltotetraose is combined with Warfarin.